Funding for this research was provided by:
Genome Canada (TIA 4125 - Penn)
Genome British Columbia (TIA 4125 - Penn)
Genome Alberta (TIA 4125 - Penn)
Received: 22 March 2019
Accepted: 16 September 2019
First Online: 25 October 2019
Ethics approval and consent to participate
: Institutional approval to conduct the research was provided by each hospital’s Ethics Review Board. This includes the Conjoint Health Research Ethics Board at the University of Calgary, Alberta, Canada (REB13-0174_REN1) and the Island Health Research Ethics Board, British Columbia, Canada (C2013–023). All patients provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.